Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s43441-020-00158-8 http://scihub22266oqcxt.onion/10.1007/s43441-020-00158-8 C7194243!7194243!33258095     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Ther+Innov+Regul+Sci 2020 ; 54 (6): 1359-62 Nephropedia Template TP {{tp|p=33258095|t=2020. Coronavirus Disease 2019 (COVID-19) Spread and Pharmacovigilance Implications: Expert Opinion |pdf=|usr=}}{{33258095}} gab.com Text Coronavirus Disease 2019 (COVID-19) Spread and Pharmacovigilance Implications: Expert Opinion JO: Ther Innov Regul Sci http://www.kidney.de/pget.php?&tw=1&pmid=33258095 #FOAvip The Coronavirus Disease 2019 (COVID-19) is rapidly spreading throughout the world after emerging in China in December 2019. Currently, there are no approved treatments for COVID-19 based on large clinical trial data, and hence, management involves infection prevention and control measures and supportive care. With anecdotal reports and in vitro studies suggesting that certain medicines already in use for treatment of other conditions could be viable treatment options, there has been an increased demand for these therapies which could have adverse consequences on patients and healthcare systems. Toxicity from these medicines resulting from a mad rush for them at community pharmacies and pressure on physicians to prescribe for individuals who do not have the infection are worth noting. Furthermore, the indiscriminate use of these medicines could result in viral resistance as well as acute shortage such that patients who routinely take them for other conditions may not get them. Twit Text FOAVip Coronavirus Disease 2019 (COVID-19) Spread and Pharmacovigilance Implications: Expert Opinion ????Ther Innov Regul Sci http://www.kidney.de/pget.php?&tw=1&pmid=33258095 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33258095 #FOAvip English Wikipedia <ref>{{Cite pmid|33258095}}</ref> Coronavirus Disease 2019 (COVID-19) Spread and Pharmacovigilance Implications: Expert Opinion #MMPMID33258095 Yamoah P; Alalbila TM; Bangalee V; Oosthuizen F Ther Innov Regul Sci 2020[]; 54 (6): 1359-62 PMID33258095show ga The Coronavirus Disease 2019 (COVID-19) is rapidly spreading throughout the world after emerging in China in December 2019. Currently, there are no approved treatments for COVID-19 based on large clinical trial data, and hence, management involves infection prevention and control measures and supportive care. With anecdotal reports and in vitro studies suggesting that certain medicines already in use for treatment of other conditions could be viable treatment options, there has been an increased demand for these therapies which could have adverse consequences on patients and healthcare systems. Toxicity from these medicines resulting from a mad rush for them at community pharmacies and pressure on physicians to prescribe for individuals who do not have the infection are worth noting. Furthermore, the indiscriminate use of these medicines could result in viral resistance as well as acute shortage such that patients who routinely take them for other conditions may not get them. äCoronavirus Disease 2019 (COVID-19) Spread and Pharmacovigilance Impli(epmc).pdf DeepDyve Pubget Overpricing